Standard Life Aberdeen faces passive pressure

Pretty much standard

Despite an auspicious first week, Standard Life Aberdeen shares continue to signal investors are less than assured about the newly combined company.

The stock gained as much as 2.8% last week, though closed on Friday up a more modest 1.8%. Standard Life (Aberdeen) has advanced some 16% since 2nd March, when Standard Life and Aberdeen Asset Management announced their intention to merge. That’s slightly more than the 13% rise by a Thomson Reuters index including leading active investment managers, of which SLA is now the largest. In other words, Standard Life Aberdeen’s efforts to fight off ‘passive’ competitors are widely expected to bear only modest fruit.

It’s worth noting that shares in the Aberdeen bit of the new co. rose around 30% between the start of the year and about a fortnight ago. That was to be expected. Its investors received the best half of the ‘merger’ deal as Aberdeen equity was diluted the most. But erstwhile Standard Life stock now represents the combined group, and that is up pretty much in line with peers.

SLA NPV

That reflects conservative merger synergies. SLA officially projected these would be around £200m a year within three years of completion, with an initial cost of £320m. On that basis, the merger returns a positive net present value, £75m—before tax—only after the fifth year. On a perpetuity basis, Thomson Reuters calculates net present value of savings as worth $1.3bn. SLA will of course keep facing ‘passive’ pressure before synergies kick in, another small red flag. For example, Standard Life's flagship £44bn Global Absolute Return Strategies fund saw £5.6bn net outflows in the first half, despite making a better than expected £362m operating profit. Such pressures will probably moderate, though it’s difficult to forecast when. Even after factoring them in, it looks like shareholders don’t believe £200m in savings each year will be sustainable.

Second-half slippage

Flows on the Aberdeen side have been just as precarious over the last few years. Its emerging markets exposure is a frequent source of volatility. SLA's joint-CEO structure is another niggle that may have capped its stock. These set ups sometimes work for global companies, but major investors don’t like them. There’s too much room for ego-fuelled disruption.

Of course, there’s scope for the new group to set new standards that eventually impress scepticism away. SLA’s below-peer group average forward rating also offers leeway. But short of a strongly accretive growth spurt, Standard Life Aberdeen’s shares are unlikely to be the dons of sector by year end.

StoneX Financial Ltd (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. CFD and Forex Trading are leveraged products and your capital is at risk. They may not be suitable for everyone. Please ensure you fully understand the risks involved by reading our full risk warning.

City Index is a trading name of StoneX Financial Ltd. Head and Registered Office: 1st Floor, Moor House, 120 London Wall, London, EC2Y 5ET. StoneX Financial Ltd is a company registered in England and Wales, number: 05616586. Authorised and regulated by the Financial Conduct Authority. FCA Register Number: 446717.

City Index is a trademark of StoneX Financial Ltd.

The information on this website is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement.